Multiple domains of the mouse p19ARF tumor suppressor are involved in p53-independent apoptosis

Biochemical and Biophysical Research Communications

Volumn 301, Issue 4, 2003, Pages 1000-1010

  Matsuoka, Masaaki ^a   Kurita, Megumi ^a,b   Sudo, Haruka ^a   Mizumoto, Kiyohisa ^b   Nishimoto, Ikuo ^a   Ogata, Etsuro ^c  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KITASATO UNIVERSITY   (Japan)

^c CANCER INSTITUTE HOSPITAL   (Japan)

Author keywords

Apoptosis; Cell cycle arrest; p53; The ARF tumor suppressor

Indexed keywords

ADENOVIRUS VECTOR; PROTEIN P19; PROTEIN P53;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL CYCLE; CONTROLLED STUDY; EMBRYO; EVOLUTION; FIBROBLAST; GENE DELETION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN STABILITY;

MAMMALIA; RODENTIA;

EID: 0037459015     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(03)00080-9     Document Type: Article

References (40)

1. Quelle D.E., Zindy F., Ashmun R.A., Sherr C.J. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell. 83:1995;993-1000.
2. Bates S., Phillips A.C., Clarke P.A., Stott F., Peters G., Ludwig R.L., Vousden K.H. p14ARF links the tumour suppressors RB and p53. Nature. 395:1998;124-125.
3. Kamijo T., Zindy F., Roussel M.F., Quelle D.E., Downing J.R., Ashmun R.A., Grosveld G., Sherr C.J. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell. 91:1997;649-659.
4. Sharpless N.E., Bardeesy N., Lee K.H., Carrasco D., Castrillon D.H., Aguirre A.J., Wu E.A., Horner J.W., DePinho R.A. Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis. Nature. 413:2001;86-91.
5. Krimpenfort P., Quon K.C., Mooi W.J., Loonstra A., Berns A. Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice. Nature. 413:2001;83-86.
6. Bates S., Phillips A.C., Clarke P.A., Stott F., Peters G., Ludwig R.L., Vousden K.H. p14ARF links the tumour suppressors RB and p53. Nature. 395:1998;124-125.
7. De Stanchina E., McCurrach M.E., Zindy F., Shieh S.Y., Ferbeyre G., Samuelson A.V., Prives C., Roussel M.F., Sherr C.J., Lowe S.W. E1A signaling to p53 involves the p19(ARF) tumor suppressor. Genes Dev. 12:1998;2434-2442.
8. Palmero I., Pantoja C., Serrano M. p19ARF links the tumour suppressor p53 to Ras. Nature. 395:1998;125-126.
9. Zindy F., Eischen C.M., Randle D., Kamijo T., Cleveland J.L., Sherr C.J., Roussel M.F. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev. 12:1998;2424-2433.
10. Pomerantz J., Schreiber-Agus N., Lieois N.J., Silverman A., Alland L., Chin L., Potes J., Chen K., Orlow I., Lee H.-W., Cordon-Cardo C., DePinho R. The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell. 92:1998;713-723.
11. Zhang Y., Xiong Y., Yarbrough W.G. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell. 92:1998;725-734.
12. Stott F.J., Bates S., James M.C., McConnell B.B., Starborg M., Brookes S., Palmero I., Ryan K., Hara E., Vousden K.H., Peters G. The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2. EMBO J. 17:1998;5001-5014.
13. Kamijo T., Weber J.D., Zambetti G., Zindy F., Roussel M.F., Sherr C.J. Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2. Proc. Natl. Acad. Sci. USA. 95:1998;8292-8297.
14. Eischen C.M., Weber J.D., Roussel M.F., Sherr C.J., Cleveland J.L. Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis. Genes Dev. 13:1999;2658-2669.
15. Jacobs J.J., Scheijen B., Voncken J-W., Kieboom K., Berns A., van Lohuizen M. Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF. Genes Dev. 13:1999;2678-2690.
16. Schmitt C.A., McCurrach M.E., De Stanchina E., Wallace-Brodeur R.R., Lowe S.W. INK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53. Genes Dev. 13:1999;2670-2677.
17. Lindstrom M.S., Klangby U., Inoue R., Pisa P., Wiman K.G., Asker C.E. Immunolocalization of human p14(ARF) to the granular component of the interphase nucleolus. Exp. Cell Res. 256:2000;400-410.
18. Moller M.B., Ino Y., Gerdes A.M., Skjodt K., Louis D.N., Pedersen N.T. Aberrations of the p53 pathway components p53, MDM2 and CDKN2A appear independent in diffuse large B cell lymphoma. Leukemia. 13:1999;453-459.
19. Sanchez-Cespedes M., Reed A.L., Buta M., Wu L., W.H, Herman J.G., Yang S.C., Jen J., Sidransky D. Inactivation of the INK4A/ARF locus frequently coexists with TP53 mutations in non-small cell lung cancer. Oncogene. 18:1999;5843-5849.
20. Weber J.D., Jeffers J.R., Rehg J.E., Randle D.H., Lozano G., Roussel M.F., Sherr C.J., Zambetti G.P. p53-independent functions of the p19(ARF) tumor suppressor. Genes Dev. 14:2000;2358-2365.
21. Carnero A., Hudson J.D., Price C.M., Beach D. p16INK4A and p19ARF act in overlapping pathways in cellular immortalization. Nat. Cell Biol. 2:2000;148-155.
22. Hemmati P.G., Gillissen B., von Haefen C., Wendt J., Starck L., Guner D., Dorken B., Daniel P.T. Adenovirus-mediated overexpression of p14(ARF) induces p53 and Bax-independent apoptosis. Oncogene. 21:2002;3149-3161.
23. Yarbrough W.G., Bessho M., Zanation A., Bisi J.E., Xiong Y. Human tumor suppressor ARF impedes S-phase progression independent of p53. Cancer Res. 62:2002;1171-1177.
24. ARF tumor suppressor Biochem. Biophys. Res. Commun. 295:2002;621-629.
25. Weber J.D., Kuo M.L., Bothner B., DiGiammarino E.L., Kriwacki R.W., Roussel R.W., Sherr C.J. Cooperative signals governing ARF-mdm2 interaction and nucleolar localization of the complex. Mol. Cell. Biol. 20:2000;2517-2528.
26. Kanegae Y., Lee G., Sato Y., Tanaka M., Nakai M., Sakaki T., Sugano S., Saito I. Efficient gene activation in mammalian cells by using recombinant adenovirus expressing site-specific Cre recombinase. Nucleic Acids Res. 23:1995;3816-3821.
27. Tsuji K., Mizumoto K., Yamochi T., Nishimoto I., Matsuoka M. Differential effect of ik3-1/cables on p53- and p73-induced cell death. J. Biol. Chem. 277:2002;2951-2957.
28. Miyake S., Makimura M., Kanegae Y., Harada S., Sato Y., Takamori K., Tokuda C., Saito I. Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome. Proc. Natl. Acad. Sci. USA. 93:1996;1320-1324.
29. Mittereder N., March K.L., Trapnell B.C. Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy. J. Virol. 70:1996;7498-7509.
30. Nyberg-Hoffman C., Shabram P., Li W., Giroux D., Aguilar-Cordova E. Sensitivity and reproducibility in adenoviral infectious titer determination. Nat. Med. 3:1997;808-811.
31. Schagger H., von Jagow G. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100. kDa Anal. Biochem. 166:1987;368-379.
32. Nishihara J., Sakai M., Nishi S. Identification of ionizable groups essential for the enzyme catalysis on glutathione S-transferase. Biochem. Biophys. Res. Commun. 194:1993;1466-1474.
33. Sato H., Nishimoto I., Matsuoka M. ik3-2, a relative to ik3-1/cables, is associated with cdk3, cdk5, and c-abl. Biochim. Biophys. Acta. 1574(2):2002;157-163.
34. Brand K., Klocke R., Possling A., Paul D., Strauss M. Induction of apoptosis and G2/M arrest by infection with replication-deficient adenovirus at high multiplicity of infection. Gene Ther. 6:1999;1054-1063.
35. Sugihara T., Kaul S.C., Kato J., Reddel R.R., Nomura H., Wadhwa R. Pex19p dampens the p19ARF-p53-p21WAF1 tumor suppressor pathway. J. Biol. Chem. 276:2001;18649-18652.
36. R. Wadhwa, T. Sugihara, M.K. Hasan, K. Taira, R.R. Reddel, S.C. Kaul, A major functional difference between the mouse and human ARF tumor suppressor proteins. J. Biol. Chem. 2002 July 26 [epub ahead of print].
37. Serrano M., Lee H., Chin L., Cordon-Cardo C., Beach D., DePinho R.A. Role of the INK4a locus in tumor suppression and cell mortality. Cell. 85:1996;27-37.
38. Palmero I., Pantoja C., Serrano M. p19ARF links the tumour suppressor p53 to Ras. Nature. 395:1998;125-126.
39. Serrano M., Lin A.W., McCurrach M.E., Beach D., Lowe S.W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell. 88:1997;593-602.
40. Sharpless N.E., DePinho R.A. The INK4A/ARF locus and its two gene products. Curr. Opin. Genet. Dev. 9:1999;22-30.